A phase II study of bevacizumab, docetaxel and oxaliplatin in gastric and gastroesophageal junction (GEJ) cancer

被引：1
|
作者：
El-Rayes, B. F. [1 ]
Hammad, N. [1 ]
Philip, P. A. [1 ]
Shields, A. F. [1 ]
Heilbrun, L. K. [1 ]
机构：
[1] Wayne State Univ, Karmanos Canc Inst, Detroit, MI USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.15608
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
15608
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Multicenter phase II study of docetaxel plus oxaliplatin combination chemotherapy in patients with advanced gastric cancer
    Kim, J.
    Song, H.
    Do, Y.
    Lee, K.
    Kim, M.
    Ryu, H.
    Bae, S.
    Park, G.
    Baek, J.
    Lee, W.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [42] Phase II study of docetaxel, oxaliplatin and S-1 (DOS) for patients with advanced gastric cancer
    Zang, D.
    Kang, Y.
    Ryu, B.
    Ryu, M.
    Lee, S.
    Kim, H.
    Kim, J.
    Jung, J.
    Kwon, J.
    Kim, H.
    [J]. EJC SUPPLEMENTS, 2009, 7 (02): : 375 - 375
  • [43] Phase II study of docetaxel, oxaliplatin, and S-1 therapy in patients with metastatic gastric cancer
    Hyeong Su Kim
    Min-Hee Ryu
    Dae Young Zang
    Baek-Yeol Ryoo
    Dae Hyun Yang
    Ji Woong Cho
    Man Sup Lim
    Min-Jeong Kim
    Boram Han
    Dae Ro Choi
    Jung Han Kim
    Joo Young Jung
    Hunho Song
    Choong Kee Park
    Yoon-Koo Kang
    [J]. Gastric Cancer, 2016, 19 : 579 - 585
  • [44] Phase II study of docetaxel, oxaliplatin, and S-1 therapy in patients with metastatic gastric cancer
    Kim, Hyeong Su
    Ryu, Min-Hee
    Zang, Dae Young
    Ryoo, Baek-Yeol
    Yang, Dae Hyun
    Cho, Ji Woong
    Lim, Man Sup
    Kim, Min-Jeong
    Han, Boram
    Choi, Dae Ro
    Kim, Jung Han
    Jung, Joo Young
    Song, Hunho
    Park, Choong Kee
    Kang, Yoon-Koo
    [J]. GASTRIC CANCER, 2016, 19 (02) : 579 - 585
  • [45] OXALIPLATIN, IRINOTECAN, BEVACIZUMAB FOLLOWED BY DOCETAXEL, BEVACIZUMAB IN INOPERABLE GASTRIC CANCER. A MULTICENTER PHASE II TRIAL (AGMT GASTRIC-3) OF THE ARBEITSGEMEINSCHAFT MEDIKAMENToSE TUMORTHERAPIE (AGMT)
    Woell, E.
    Keil, F.
    Thaler, J.
    Gruenberger, B.
    Hejna, M.
    Eisterer, W.
    Fridrik, M. A.
    Romeder, F.
    Greil, R.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 249 - 250
  • [46] Envafolimab plus chemotherapy in advanced gastric or gastroesophageal junction (G/GEJ) cancer.
    Yin, Xianli
    Zhang, Yun
    Deng, Yanhong
    Xu, Nong
    Xu, Jianming
    Li, Lei
    Song, Xiaotong
    Lu, Haolan
    Gong, John
    Liu, Dongfang
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [47] Phase I study to evaluate the safety, tolerability and preliminary efficacy of rivoceranib plus paclitaxel in advanced gastric or gastroesophageal junction (GEJ) cancer
    Ryu, M. H.
    Pande, A.
    Kim, J. H.
    Kang, Y-K.
    [J]. ANNALS OF ONCOLOGY, 2022, 33 (07) : S1114 - S1114
  • [48] Phase II trial of sorafenib in esophageal (E) and gastroesophageal junction (GEJ) cancer: Response observed in adenocarcinoma.
    Ilson, D.
    Shah, M. A.
    Kelsen, D. P.
    Janjigian, Y. Y.
    Tang, L. H.
    Campbell, J.
    Fuqua, L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [49] Phase 1a/1b and pharmacogenetic study of docetaxel, oxaliplatin and capecitabine in patients with advanced cancer of the stomach or the gastroesophageal junction
    Maarten J. Deenen
    Didier Meulendijks
    Henk Boot
    Marie-Cecile J. C. Legdeur
    Jos H. Beijnen
    Jan H. M. Schellens
    Annemieke Cats
    [J]. Cancer Chemotherapy and Pharmacology, 2015, 76 : 1285 - 1295
  • [50] Phase II Study of Modified Docetaxel, Cisplatin, and Fluorouracil With Bevacizumab in Patients With Metastatic Gastroesophageal Adenocarcinoma
    Shah, Manish A.
    Jhawer, Minaxi
    Ilson, David H.
    Lefkowitz, Robert A.
    Robinson, Edric
    Capanu, Marinela
    Kelsen, David P.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07) : 868 - 874
12345